You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
期權大單 | 大單做多默沙東、吉利德等醫藥股,成交量激增
uSMART盈立智投 12-14 18:11

一、期權異動

12月13日,美股默沙東、吉利德、Moderna等標的出現了期權成交量上的較大變化,分別爲日常成交量的11.8、15.2、5倍。

美股醫藥股普漲,默沙東、吉利德科學、Moderna期權成交量激增,其中,默沙東期權成交389,830張合約,是日均成交的11.8倍,看漲期權佔比96%;吉利德科學期權成交333,221張合約,是日均成交的15.2倍,看漲期權佔比96.9%;Moderna期權成交241,775張合約,是日均成交的5倍,看漲期權佔比62.9%。

Pinterest收漲近12%,報26.42美元;週二期權成交174,369張合約,其中看漲期權佔比75.1%;其中2023年3月17日到期的27.5美元行使價看漲期權的成交量特別高,成交量爲20,408張。

二、總成交量前10

美東時間週二,在美聯儲利率決議前夕,11月CPI超預期放緩,但市場仍擔心美聯儲可能繼續大舉加息,這導致三大指數高開低走集體收漲。截至收盤,道指收漲103.60點,漲幅爲0.30%,報34108.64點;納指漲113.08點,漲幅爲1.01%,報11256.81點;標普500指數漲29.09點,漲幅爲0.73%,報4019.65點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account